Zobrazeno 241 - 250
of 1 871
pro vyhledávání: '"van Bodegraven, A. A."'
Publikováno v:
van Bodegraven, A A, Mulder, C J J & Bravenboer, N 2020, Osteoporosis associated with gastrointestinal disorders : Celiac and inflammatory bowel diseases . in Marcus and Feldman’s Osteoporosis . Marcus and Feldman’s Osteoporosis, Elsevier, pp. 1069-1082 . https://doi.org/10.1016/B978-0-12-813073-5.00043-5
Marcus and Feldman’s Osteoporosis, 1069-1082
STARTPAGE=1069;ENDPAGE=1082;TITLE=Marcus and Feldman’s Osteoporosis
Marcus and Feldman’s Osteoporosis, 1069-1082
STARTPAGE=1069;ENDPAGE=1082;TITLE=Marcus and Feldman’s Osteoporosis
Impaired bone health is a common complication of chronic inflammatory intestinal diseases, such as celiac disease and inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis, already at diagnosis and during follow-up. Osteopen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::148005cfe763af6bcf422e2d658825a9
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85126412859&origin=inward
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85126412859&origin=inward
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M.A.E. de van der Schueren, Laurien G. P. H. Vroomen, Nicolette J. Wierdsma, Hester J. Scheffer, J. E. Witvliet-van Nierop, A.A. van Bodegraven, Martijn R. Meijerink
Publikováno v:
Witvliet-van Nierop, J E, de van der Schueren, M A E, Scheffer, H J, Vroomen, L G, Meijerink, M R, van Bodegraven, A A & Wierdsma, N J 2019, ' Exocrine pancreatic and enterocyte function in patients with advanced pancreatic cancer ', Clinical Nutrition, vol. 38, no. 6, pp. 2778-2782 . https://doi.org/10.1016/j.clnu.2018.12.005
Clinical Nutrition, 38(6), 2778-2782. Churchill Livingstone
Clinical Nutrition, 8
Clinical Nutrition, 38(6), 2778-2782. Churchill Livingstone
Clinical Nutrition, 8
BACKGROUND & AIMS: Exocrine pancreatic function is affected in patients with locally advanced pancreatic cancer (LAPC), clinically leading to steatorrhea. It is unknown whether maldigestion and malabsorption can also be attributed to impaired intesti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcb00e8508fea30fe19e1bd00558b14a
https://research.vumc.nl/en/publications/6dbefb79-b005-4dee-aa26-2b1b2006ffba
https://research.vumc.nl/en/publications/6dbefb79-b005-4dee-aa26-2b1b2006ffba
Publikováno v:
5% Arquitetura + Arte, Pp e109-e109 (2019)
Desde o início da implantação das indústrias no Brasil, com a chegada da corte portuguesa em terras brasileiras e a assinatura do Alvará de 1808, por D. João VI, que autorizou a instalação de fábricas e manufaturas no país e revogou o Alvar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::de889c301fb023cb358d1a49744bf6ac
http://revista5.arquitetonica.com/ojs/index.php/revista5/article/view/109
http://revista5.arquitetonica.com/ojs/index.php/revista5/article/view/109
Autor:
Andras Süle, Claude Le Pen, Antonio Llombart-Cussac, Ad A van Bodegraven, Antonella Celano, Ferdinand Breedveld, Niels Boone, Rene Westhovens, Frank Jorgensen, Steven Simoens, Jo De Cock
Publikováno v:
Generics and Biosimilars Initiative Journal. 7:70-74
Autor:
de groof, E. Joline, Stevens, Toer W., Eshuis, Emma J., Gardenbroek, Tjibbe J., Bosmans, Judith E., van Dongen, J. M., Mol, Bregje, Buskens, Christianne J., Stokkers, Pieter C. F., Hart, Ailsa, D'Haens, Geert R., Bemelman, Willem A., Ponsioen, Cyriel Y., Warusavitarne, Janindra, van Bodegraven, Ad A., Brink, Menno A., J Consten, Esther C., van Wagensveld, Bart A., M Rijk, Marno C., P H Crolla, Rogier M., Noomen, Casper G., J Houdijk, Alexander P., Mallant, Rosalie C., Boom, Maarten, Marsman, Willem A., Stockmann, Hein B., Bruin, Karlien, Maring, John, Ditzhuijsen, Theo van, Prins, Hubert, den Brande, Jan van, Kingma, Paul, Geloven, Anna van, de Boer, Nanne, der Peet, Donald van, Jansen, Jeroen, Gerhards, Michael, van der Woude, Janneke, Schouten, Ruud, Oldenburg, Bas, van Hillegersberg, Richard, West, Rachel, Mannaerts, Guido, Spanier, Marcel, Spillenaar Bilgen, Ernst Jan, Lieverse, Rob, der Zaag, Edwin van, Depla, Annekatrien, de Laar, Arnold van, Cahen, Djuna
Publikováno v:
Gut, 68(10), 1774-1780. BMJ Publishing Group
LIR!C study group 2019, ' Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn's disease: The LIR!C Trial ', Gut, vol. 68, no. 10, pp. 1774-1780 . https://doi.org/10.1136/gutjnl-2018-317539
LIR!C study group 2019, ' Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn's disease : the LIR!C Trial ', Gut, vol. 68, no. 10, pp. 1774-1780 . https://doi.org/10.1136/gutjnl-2018-317539
LIR!C study group 2019, ' Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn's disease: The LIR!C Trial ', Gut, vol. 68, no. 10, pp. 1774-1780 . https://doi.org/10.1136/gutjnl-2018-317539
LIR!C study group 2019, ' Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn's disease : the LIR!C Trial ', Gut, vol. 68, no. 10, pp. 1774-1780 . https://doi.org/10.1136/gutjnl-2018-317539
ObjectiveEvaluate the cost-effectiveness of laparoscopic ileocaecal resection compared with infliximab in patients with ileocaecal Crohn’s disease failing conventional therapy.DesignA multicentre randomised controlled trial was performed in 29 cent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33beb7ba57c11fe479457929b9950b8d
https://research.vu.nl/en/publications/07645e75-4625-4913-83c3-93d5170f8e1d
https://research.vu.nl/en/publications/07645e75-4625-4913-83c3-93d5170f8e1d
Autor:
C. Houwen, L. Duijsens, Ralph Peeters, Robert Landewé, Niels Boone, Rob Janknegt, Mariëlle Romberg-Camps, A. A. van Bodegraven, Bjorn Winkens, L. Liu, P. H. M. van der Kuy
Publikováno v:
European Journal of Clinical Pharmacology, 74(5), 655-661. Springer
European Journal of Clinical Pharmacology, 74(5), 655-661. Springer-Verlag
European Journal of Clinical Pharmacology
European journal of clinical pharmacology, 74(5), 655-661. Springer Verlag
European Journal of Clinical Pharmacology, 74(5), 655-661. Springer-Verlag
European Journal of Clinical Pharmacology
European journal of clinical pharmacology, 74(5), 655-661. Springer Verlag
Background In clinical practice, non-medical switching of biological medication may provoke nocebo effects due to unexplained deterioration of therapeutic benefits. Indication extrapolation, idiosyncratic reactions, and interchangeability remain chal
Autor:
Berrie Meijer, Melek Simsek, Chris J. J. Mulder, Adriaan A. van Bodegraven, Nanne K. H. de Boer
Publikováno v:
Simsek, M, Meijer, B, van Bodegraven, A A, de Boer, N K H & Mulder, C J J 2018, ' Finding hidden treasures in old drugs : the challenges and importance of licensing generics ', Drug Discovery Today, vol. 23, no. 1, pp. 17-21 . https://doi.org/10.1016/j.drudis.2017.08.008
Identifying new indications for existing drugs creates new therapeutic options while bypassing much of the costs and time involved with bringing a new drug to market. The rediscovery of a generic drug, however, is a challenging pursuit because there